In 59 pregnant people with hyperemesis gravidarum, mirtazapine reduced PUQE-24 score at day 2 vs placebo (difference -1.86, P=.04); ondansetron vs placebo was not significant (-0.51). Mild to moderate adverse events were more common with mirtazapine.
RCTn = 59
Ostenfeld et al. Mirtazapine or ondansetron for hyperemesis gravidarum: a randomized placebo-controlled trial